pyrazines has been researched along with bn 80933 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auguet, M; Chabrier, PE; Demerlé-Pallardy, C | 1 |
| Dawson, VL | 1 |
| Auguet, M; Auvin, S; Bigg, D; Chabrier, PE; Cornet, S; Demerlé-Pallardy, C; Gillard-Roubert, V; Guilmard-Favre, C; Marin, JG; Moncada, S; Pignol, B; Roussillot-Charnet, C; Schulz, J; Spinnewyn, B; Viossat, I | 1 |
| Auguet, M; Chabrier, PE; Demerlé-Pallardy, C; Gillard-Roubert, V; Marin, JG | 1 |
| Auguet, M; Chabrier, PE; Cornet, S; Demerlé-Pallardy, C; Marin, JG; Spinnewyn, B | 1 |
| Chabrier, PE; Croci, N; Ding-Zhou, L; Marchand-Verrecchia, C; Margaill, I; Palmier, B; Plotkine, M | 1 |
2 review(s) available for pyrazines and bn 80933
| Article | Year |
|---|---|
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes | 1999 |
Potent neuroprotectants linked to bifunctional inhibition.
Topics: Animals; Brain; Brain Ischemia; Enzyme Inhibitors; Free Radical Scavengers; Mice; Models, Biological; Neuroprotective Agents; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Pyrazines; Rats; Thiophenes | 1999 |
4 other study(ies) available for pyrazines and bn 80933
| Article | Year |
|---|---|
BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: a promising neuroprotective strategy.
Topics: Animals; Aorta; Brain Injuries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gerbillinae; Inhibitory Concentration 50; Kinetics; Lipid Peroxidation; Male; Mice; Myocardial Ischemia; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Organ Culture Techniques; Pyrazines; Rats; Rats, Sprague-Dawley; Thiophenes; Time Factors | 1999 |
In vitro antioxidant neuroprotective activity of BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation.
Topics: Animals; Antioxidants; Cell Line; Cerebral Cortex; Dinoprost; Enzyme Inhibitors; F2-Isoprostanes; Glutathione; Hypoxia; L-Lactate Dehydrogenase; Lipid Peroxides; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxidative Stress; Pyrazines; Rats; Rats, Wistar; Thiophenes | 2000 |
BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures.
Topics: Animals; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Dinoprost; Enzyme Inhibitors; F2-Isoprostanes; Hypoxia, Brain; Infarction, Middle Cerebral Artery; L-Lactate Dehydrogenase; Neuroprotective Agents; Pyrazines; Rats; Rats, Wistar; Reperfusion Injury; Thiophenes | 2000 |
Neuroprotective effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an inhibitor of neuronal nitric-oxide synthase and an antioxidant, in model of
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain Edema; Brain Infarction; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Male; Mice; Nervous System Diseases; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peroxidase; Pyrazines; Thiophenes | 2003 |